Sofinnova Investments, Inc.
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1631134
Menlo Park, CA
Position in SUPN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$48,199,615
-$1,128,617 QoQ
Shares Held
1,036,328
+8.6% QoQ
Ownership
1.78%
of shares outstanding
% of Portfolio
2.58%
of 13F equity value
Holder Rank
#16
of 333 holders
Holding Since
Jun 2020
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Sofinnova Investments, Inc. holds $145,864,392 across 3 Drug Manufacturers - Specialty & Generic names. SUPN ranks #2 (33.0% of the industry book) .
All Filings in SUPN
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $48,199,615 | 1,036,328 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $49,328,232 | 954,309 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $27,488,821 | 553,095 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $18,019,984 | 377,066 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $25,192,454 | 799,253 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $17,052,204 | 520,678 | Shares | Sole | 2025-05-15 | |
| 2020-09-30 | $6,883,346 | 330,295 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $11,360,313 | 478,329 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||